Search Medical Condition
Please enter condition
Please choose location from dropdown

Atrial Fibrillation Clinical Trials

A listing of Atrial Fibrillation medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (512) clinical trials

The primary objective is to show the benefit of SmartDelay™ in patients with a prolonged RV-LV interval.

Phase N/A

To determine if the use of apixaban in patients with SCAF will reduce the incidence of stroke and systemic embolism compared to aspirin.

Phase N/A

This study is a prospective, randomized, multi-center, global investigation to determine the safety and effectiveness of the WATCHMAN Device for subjects with non-valvular atrial fibrillation who are deemed not suitable for anticoagulation therapy to reduce the risk of stroke.

Phase N/A

Atrial fibrillation affects approximately 2 million Americans according to the American Heart Association. This patient population comprises a substantial portion of patients seen at Baptist Health Lexington. Means of treatment includes pharmacological therapy for controlling both the rate and rhythm. In many cases, also anticoagulants are also necessary to prevent ...

Phase N/A

Catheter ablation has been used for over a decade to treat AF patients to achieve PVI. Significant catheter design improvements (e.g., irrigated encircling catheters) focus upon improving physicians’ abilities to achieve finite entrance block following PVI. The primary intent of this study is to generate clear and sufficient safety and ...

Phase N/A

Numerous clinical studies have evaluated the benefits of biventricular pacing compared to optimal medical therapy1,2. However, some patients, who have undergone a successful implantation of a biventricular pacing device, do not have a measurable improvement in cardiac performance or symptoms3. Such patients are generally considered to be CRT non-responders. Clinical ...

Phase N/A

Heart failure (HF) is a major threat to public health affecting 5.8 million individuals in the United States (U.S.). It is estimated that one in five people who have heart failure die within one year from diagnosis1. Several randomized clinical trials have demonstrated the benefits of heart failure patients receiving ...

Phase N/A

Heart failure (HF) is a major public health issue with a current prevalence of 2-3% in the total and 10-20% in the aged population (Lloyd-Jones et al., 2010). The overall prevalence for heart failure is increasing due to ageing population. Additional factors are the success of the modern therapies in ...

Phase N/A

The purpose of this research study is to collect data on the clinical utility of the MediGuide system. This study does not require additional tests; all of the tests for this study are part of your normal care and would be done even if you were not in the study. ...

Phase N/A

Prospective, multicenter, randomized, active control, clinical trial of the Coherex WaveCrest Left Atrial Appendage (LAA) device compared to the Watchman® LAA device for the reduction in risk of ischemic stroke or systemic embolism in subjects with non-valvular atrial fibrillation who have an appropriate rationale to seek a non-pharmacologic alternative to ...

Phase N/A